Literature DB >> 20807022

Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination.

Sirpa Räsänen1, Suvi Lappalainen, Anne Halkosalo, Marjo Salminen, Timo Vesikari.   

Abstract

Rotaviruses (RV) are major causative agents of acute gastroenteritis (AGE) requiring hospitalization in children; RV hospitalizations may be largely eliminated by universal mass vaccination with RV vaccine. We conducted a hospital-based prospective survey of AGE in children over 2 RV epidemic seasons, from 2006 to 2008, when the coverage of RV vaccination in Finland increased to 35% of the birth cohort. RVs were detected by reverse transcription polymerase chain reaction (RT-PCR). In the first season, only 38% of AGE cases were RV-positive, and the onset of the RV season was delayed. Type G1P[8], RVs accounted for 40%, G2P[4] for 19%, G3P[8] for 2%, G4P[8] for 2% and G9P[8] for 38%. In the second season, 63% of AGE cases were RV-positive: G1P[8] accounted for 73%, G2P[4] for only 3%, G3P[8] for 4%, G4P[8] for 13%, and G9P[8] had almost disappeared. G2P[4] RV did not become predominant at the coverage level of 29% of G1P[8] human RV vaccine. RV-associated hospitalizations were seen in children up to the age of 9 y. This study forms the epidemiological background for the follow-up of the impact of universal RV vaccination in Finland introduced in 2009.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20807022     DOI: 10.3109/00365548.2010.508462

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  9 in total

1.  Norovirus Loads in Stool Specimens of Cancer Patients with Norovirus Gastroenteritis.

Authors:  Taojun He; Tracy A McMillen; Yuanyuan Qiu; Liang Hua Chen; Xuedong Lu; Xiao-Li Pang; Mini Kamboj; Yi-Wei Tang
Journal:  J Mol Diagn       Date:  2017-08-12       Impact factor: 5.568

2.  Rotavirus genotypes in sewage treatment plants and in children hospitalized with acute diarrhea in Italy in 2010 and 2011.

Authors:  Franco M Ruggeri; Paolo Bonomo; Giovanni Ianiro; Andrea Battistone; Roberto Delogu; Cinzia Germinario; Maria Chironna; Maria Triassi; Rosalba Campagnuolo; Antonella Cicala; Giovanni M Giammanco; Paolo Castiglia; Caterina Serra; Andrea Gaggioli; Lucia Fiore
Journal:  Appl Environ Microbiol       Date:  2014-10-24       Impact factor: 4.792

Review 3.  Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure?

Authors:  Renáta Dóró; Brigitta László; Vito Martella; Eyal Leshem; Jon Gentsch; Umesh Parashar; Krisztián Bányai
Journal:  Infect Genet Evol       Date:  2014-09-16       Impact factor: 3.342

4.  Impact of self-financed rotavirus vaccination on acute gastroenteritis in young children in Turkey.

Authors:  Erdem Gönüllü; Ahmet Soysal; İsmail Yıldız; Metin Karaböcüoğlu
Journal:  Hum Vaccin Immunother       Date:  2020-07-23       Impact factor: 3.452

5.  Noroviruses in children seen in a hospital for acute gastroenteritis in Finland.

Authors:  Sirpa Räsänen; Suvi Lappalainen; Marjo Salminen; Leena Huhti; Timo Vesikari
Journal:  Eur J Pediatr       Date:  2011-04-05       Impact factor: 3.183

6.  Sustained High Effectiveness of RotaTeq on Hospitalizations Attributable to Rotavirus-Associated Gastroenteritis During 4 Years in Finland.

Authors:  Maria Hemming-Harlo; Timo Vesikari; Matti Uhari; Marjo Renko; Marjo Salminen; Laurence Torcel-Pagnon; Susanne Hartwig; Francois Simondon; Hélène Bricout
Journal:  J Pediatric Infect Dis Soc       Date:  2017-11-24       Impact factor: 3.164

7.  Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq®.

Authors:  Susanne Hartwig; Matti Uhari; Marjo Renko; Perrine Bertet; Maria Hemming; Timo Vesikari
Journal:  BMC Health Serv Res       Date:  2014-12-11       Impact factor: 2.655

8.  Human bocavirus types 1, 2 and 3 in acute gastroenteritis of childhood.

Authors:  Minna Risku; Minna Kätkä; Suvi Lappalainen; Sirpa Räsänen; Timo Vesikari
Journal:  Acta Paediatr       Date:  2012-05-24       Impact factor: 2.299

9.  Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland.

Authors:  Maria Hemming; Sirpa Räsänen; Leena Huhti; Minna Paloniemi; Marjo Salminen; Timo Vesikari
Journal:  Eur J Pediatr       Date:  2013-01-30       Impact factor: 3.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.